NCT04018339View on ClinicalTrials.gov

A Study of RTA 402 in Obese Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 20, 2019

Primary Completion Date

May 28, 2020

Study Completion Date

June 18, 2020

Conditions
Obese Adult Male
Interventions
DRUG

Bardoxolone methyl

Bardoxolone methyl 5 mg capsules

DRUG

Placebo

Capsules containing an inert placebo

Trial Locations (1)

830-0011

Applied Bio-Pharmatech Kurume Clinical Pharmacology Clinic, Kurume

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT04018339 - A Study of RTA 402 in Obese Adults | Biotech Hunter | Biotech Hunter